All Q2 FY26 results →
CF

Chambal Fert.

Q2 FY26Fertilizers & Agrochemicals

Chambal Fert. Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹431
Market cap₹17.3K Cr
P/E9.0
Updated23 Aug 2026
Read4 min read

The short version

Chambal Fertilisers expects continued volume and revenue growth, particularly in P&K fertilisers, with volumes touching around 1.1 million tons this year, nearly doubling from last year. The company expects growth driven by expansion in business lines and increasing employee base aligned with these developments.

From Chambal Fert.'s Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Chambal Fertilisers expects continued volume and revenue growth, particularly in P&K fertilisers, with volumes touching around 1.1 million tons this year, nearly doubling from last year.
  • Crop Protection and Speciality Nutrients show strong traction with a 28-29% year-on-year revenue growth and 37% growth in contribution margins; 22 new products were launched in HY1 FY ‘25-‘26.
  • The digital platform aims to grow from current ~80,000-90,000 subscribers to 3-5 lakh subscribers by next year, enhancing farmer engagement and outreach.
  • Urea demand is expected to grow 2.5%-3% annually due to intensified cropping patterns, with potential capacity expansion under consideration aligned with government policies.

2 more points from Chambal Fert.'s call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Chambal Fert. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The Company is continuously undertaking routine capital expenditure for energy efficiency projects and equipment replacement.
  • A balance amount remains to be spent on expanding TAN (Technical Ammonium Nitrate) production.
  • Plans to consider expansion in allied lines of business are in progress, requiring Board approval based on alignment and return criteria.
  • Discussions around potential urea capacity expansion depend on government policy; Chambal is ready to evaluate and act if policies are favorable.
  • The TAN plant trial run is on schedule, with operations expected to start by January 2026.

2 more points from Chambal Fert.'s call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chambal Fert. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from the Chambal Fertilisers and Chemicals Limited Q2 and H1 FY ‘26 earnings call does not explicitly mention details regarding the current or expected order book or pending orders of the company. The discussion focuses more on production volumes, sales performance, capacity, market conditions, product portfolio, expansion plans, and financial metrics such as revenue, EBITDA, and profit. No specific figures or commentary on order backlog or pending orders are disclosed in the available pages. If you need insights on order book or pending orders, additional specific sections or updates may be required.

Chambal Fert. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.8K Cr, net profit ₹169 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chem. (Q2 FY26)

    140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran

  • Krishana Phosch. (Q2 FY26)

    Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions. Key concall takeaways from Krishana Phoschem…

  • Sumitomo Chemi. (Q2 FY26)

    Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…

  • Anya Polytech & (Q2 FY26)

    Packaging segment EBITDA margin is around 10%-12%, while fertilizer segment EBITDA margin is about 20%. Key concall takeaways from Anya Polytech &'s Q2 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chambal Fert. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chambal Fert. Q2 FY26 results?

Chambal Fertilisers expects continued volume and revenue growth, particularly in P&K fertilisers, with volumes touching around 1.1 million tons this year, nearly doubling from last year. The company expects growth driven by expansion in business lines and increasing employee base aligned with these developments.

What is Chambal Fert. share price analysis?

Chambal Fert. currently shows a neutral. The stock trades at a P/E of 9.0 with a market cap of ₹17,274 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chambal Fert. planning capital expenditure?

The Company is continuously undertaking routine capital expenditure for energy efficiency projects and equipment replacement.

Keep Chambal Fert. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.